Screener
First Tracks Biotherapeutics Inc TRAX Internal Expense — General And Administrative Expense
Other product segments
Similar metrics at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total Internal R&D(2) | 15,313 | 13,687 |
| Total R&D | 33,955 | 41,465 |
| External G&A(3) | 8,721 | 3,848 |
| Internal G&A(2) | 10,135 | 5,967 |
| Total G&A | 18,856 | 9,815 |
| Total operating expenses | 52,811 | 51,280 |
| Loss from operations | (52,811) | (51,280) |
| Interest income | 2,328 | 4,091 |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's internal expense — general and administrative expense?
- First Tracks Biotherapeutics Inc (TRAX) reported internal expense — general and administrative expense of $10.14M in Q1 2026.
- What does internal expense — general and administrative expense mean?
- This metric represents the internal costs allocated to the general and administrative functions specifically associated with the development or operational activities of a particular business segment. It captures overhead expenses such as management salaries, office facilities, and administrative support that are not directly attributable to research or production but are necessary for segment operations. Tracking this allows management to understand the true fully-loaded cost structure of individual business units.
Ask your AI about First Tracks Biotherapeutics Inc's internal expense — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude